Organon & Co.: Hypertension trials

The registry lists 25 Hypertension studies with Organon & Co. as lead sponsor. 0 are open to participants now and 14 have results posted.

Phase 1 2Phase 3 15Phase 4 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)CompletedNCT01431508Phase 4Results posted
• A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)CompletedNCT01390415Results posted
• Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)CompletedNCT01368185Results posted
• MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)CompletedNCT01307046Phase 3Results posted
• A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)CompletedNCT01307033Phase 3Results posted
• Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)CompletedNCT01277822Phase 4Results posted
• Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)CompletedNCT00953680Phase 1Results posted
• The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)CompletedNCT00943852Phase 1Results posted
• Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)CompletedNCT00756938Phase 3Results posted
• SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)CompletedNCT00739674Phase 3Results posted
• BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)CompletedNCT00546754Phase 3Results posted
• LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)CompletedNCT00496834Phase 4Results posted
• A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)TerminatedNCT00447603Phase 3Results posted
• Obese Hypertension Study (0954-315)CompletedNCT00289887Phase 3Results posted
• Cozaar XQ Re-examination Study (MK-0954-349)CompletedNCT01041807
• Health Assessment Study (0954-946)CompletedNCT00541684Phase 3
• HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)CompletedNCT00480805Phase 3
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)TerminatedNCT00449111Phase 3
• Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)CompletedNCT00400218Phase 3
• Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)CompletedNCT00398541Phase 3
• Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)CompletedNCT00338260Phase 3
• MK0954A-264 Filter Study (0954A-264)(COMPLETED)CompletedNCT00307060Phase 3
• Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)CompletedNCT00140959Phase 4
• ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)CompletedNCT00140907Phase 4
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)CompletedNCT00092209Phase 3